Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 1 5Phase 1/2 3Phase 4 2Phase 3 2Phase EARLY_PHASE1 1Phase 2/3 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Conditions

Arthritis, Rheumatoid 2

Interventions

Dexamethasone 56Metformin 50Cyclophosphamide 47Saline Solution 39Cytarabine 37Cisplatin 36Zoledronic Acid 34Letrozole 34Carboplatin 33Sodium Chloride 32Bupivacaine 31Docetaxel 30Bevacizumab 30Vincristine 29Methotrexate 29Fluorouracil 28Propofol 27Capecitabine 27Fentanyl 26Doxorubicin 26Rituximab 25Drug Therapy 25Dexmedetomidine 25Prednisone 23Paclitaxel 23Oxaliplatin 21Morphine 21Gemcitabine 21Radiotherapy 19Prednisolone 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Interventional × Leflunomide × Clear all
NCT03449758 2022-04-28

SariPRO

Sanofi

Phase 4 Completed
84 enrolled 36 charts

Arthritis, Rheumatoid

NCT02878161 2016-08-25

Predictability Studies on the Efficacy of TNF-α Inhibitors in Chinese RA From "Real World"

Central South University

Phase 4 Unknown
240 enrolled

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡